Detalhe da pesquisa
1.
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
Am J Hematol
; 97(8): 1035-1043, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583199
2.
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment.
Am J Hematol
; 97(11): 1443-1452, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054614
3.
Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations.
Am J Hematol
; 95(11): E313-E315, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804409
4.
Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia.
Blood Rev
; 64: 101156, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040614
5.
Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia.
Cancers (Basel)
; 15(14)2023 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509251
6.
Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance.
Cancers (Basel)
; 15(5)2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900407
7.
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Blood Adv
; 7(9): 1899-1909, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441905
8.
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.
Blood Cancer Discov
; 4(6): 452-467, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698624
9.
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome.
Blood Adv
; 7(11): 2378-2387, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973199
10.
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
Blood Cancer Discov
; 4(4): 276-293, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102976
11.
Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia.
Ther Adv Hematol
; 13: 20406207221093964, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35510212
12.
Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia: An Evolving Treatment Landscape.
Cancer J
; 28(1): 21-28, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35072370
13.
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
Leukemia
; 36(5): 1343-1350, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279700
14.
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.
Lancet Haematol
; 9(5): e350-e360, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483396
15.
Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.
Clin Lymphoma Myeloma Leuk
; 21(11): e895-e902, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376374
16.
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.
J Clin Oncol
; 39(25): 2768-2778, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043428
17.
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
Blood Adv
; 5(8): 2173-2183, 2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33885753
18.
Venetoclax in acute myeloid leukemia - current and future directions.
Leuk Lymphoma
; 61(6): 1313-1322, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32031033
19.
Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens.
Blood Adv
; 4(7): 1311-1320, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251497
20.
Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
Curr Hematol Malig Rep
; 14(5): 386-394, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350639